Mutant Molecules of Interest in Myeloproliferative Neoplasms
KIT and Mastocytosis
Fibroblast Growth Factor Receptor and Platelet-Derived Growth Factor Receptor Abnormalities in Eosinophilic Myeloproliferative Disorders
RAS Pathway Mutations in Juvenile Myelomonocytic Leukemia
BCR-ABL in Chronic Myelogenous Leukemia - How Does It Work?
JAK2 and MPL Mutations in Myeloproliferative Neoplasms
Leukemic Cluster Growth in Culture Is an Independent Risk Factor for Acute Myeloid Leukemia and Short Survival in Patients with Myelodysplastic Syndrome
Control of Ovulation-Induced Hemoperitoneum by Oral Contraceptives in a Patient with Congenital Hypoprothrombinemia and in Another with Congenital Factor V Deficiency
The Presence or Absence of Latent Epstein-Barr Virus Does Not Alter the Sensitivity of Burkitt's Lymphoma Cell Lines to Proteasome Inhibitors
Von Willebrand Factor-Specific Antibodies Developing upon Treatment of FVIII-Deficient Mice with Different FVIII Preparations